A Scientific Statement outlining quality standards and best practices for preclinical cardio-oncology research, intended to promote standardization, reproducibility, and rigor in the field.
Single-centre, cross-sectional observational study without randomisation or control arm design; descriptive prevalence data with comparisons to a matched external cohort, not a causal or intervention study.
This is a clinical commentary synthesizing evidence on mechanical circulatory support in high-risk PCI, reflecting regulatory guidance and expert interpretation rather than reporting a primary trial result.
A consensus statement from an international academic consortium defining standardized endpoints for LAAC trials to harmonize research quality and regulatory evaluation.
A narrative review and expert consensus statement on health equity in cardiovascular medicine that synthesizes epidemiological data and calls for a new scientific and implementation approach, but does not report original trial results or new empirical evidence.
This is an editorial overview and state-of-the-art review summarizing current understanding of residual lipid risk, therapeutic advances, and clinical management recommendations rather than reporting original research findings.